Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Posted on 21/05/202521/05/2025 by sciencefather

Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Dr. Rajashree Patnaik, MBRU, United Arab Emirates

Dr. Rajashree Patnaik is a dedicated biotechnology researcher specializing in inflammation, cancer, and stem cell biology. She earned her Ph.D. in Biotechnology in 2018 from Siksha ‘O’ Anusandhan University, India, with a focus on environmental toxicology using human cord blood stem cells. Currently a Postdoctoral Researcher at MBRU, UAE 🇦🇪, she investigates bioceuticals, statins, and venom-derived peptides in disease models. A Gold Medalist 🎖️ in both BSc and MSc, she has published extensively in international journals and received multiple accolades, including the QUWA Research Award 🏆 and Best Poster Award at an international stem cell conference.

Publication Profile

Google Scholar

Education

Dr. Rajashree Patnaik 🎓 earned her Ph.D. in Biotechnology from Siksha ‘O’ Anusandhan University, Bhubaneswar, in February 2018. Her thesis focused on monitoring the toxicity of environmental chemicals using cultured stem cells from human cord blood 🧪🧫. She is skilled in FACS, cell culture, ELISA, Western Blot, RT-PCR, fluorescence microscopy, and karyotyping 🔬. Dr. Patnaik also holds an MSc in Biotechnology (2009–2011) from Berhampur University, where she studied the impact of climate change on plant productivity 🌱. She completed six months of training at the Institute of Life Sciences, JNU, and has a BSc in Zoology (Hons.).

Awards

Dr. Rajashree Patnaik 🌟 has been honored with the Excellence in Research Award for the Best Research Proposal at the 5th Forum for Women in Research – QUWA, UOS 👩‍🔬. She also received the Best Poster Award at the International Conference on Stem Cells, Cancer & Biotechnology held in Goa, India, in 2016 🧬🏆. Dr. Patnaik is a two-time Gold Medalist, having earned top honors in both her MSc in Biotechnology (2011) and BSc in Zoology (Hons.) from Berhampur University, India 🎖️🎓. Her dedication to science and innovation continues to earn her recognition and inspire excellence.

Research Focus

Dr. Rajashree Patnaik primarily focuses on toxicology, stem cell research, natural product pharmacology, and anti-inflammatory interventions using both traditional and modern scientific methods. Her research spans in vitro cytotoxicity, phytochemical analysis, chemotherapeutic screening, and regenerative medicine, particularly investigating natural compounds like curcumin, oleocanthal, and herbal extracts against microbial pathogens, cancer, and inflammatory diseases. She is also active in exploring NOACs, environmental toxins, and PAR-2-mediated pathways in disease contexts like osteoarthritis and cancer. Her interdisciplinary work integrates cell biology, pharmacognosy, and biomedical applications.

Publication Top Notes

In vitro antibacterial activity, gas chromatography–mass spectrometry analysis of Woodfordia fruticosa Kurz. leaf extract and host toxicity testing with in vitro cultured …

Human dental pulp stem cells differentiation to neural cells, osteocytes and adipocytes-An in vitro study

Reconnoitering the therapeutic role of curcumin in disease prevention and treatment: Lessons learnt and future directions

An in vitro study of Ocimum sanctum as a chemotherapeutic agent on oral cancer cell-line

In vitro combinational efficacy of ceftriaxone and leaf extract of Combretum albidum G. Don against multidrug-resistant Pseudomonas aeruginosa and host-toxicity testing with …

Evaluation of geno-toxicity of methyl parathion and chlorpyrifos to human liver carcinoma cell line (HepG2)

Comparative study on toxicity of methylmercury chloride and methylmercury hydroxide to the human neuroblastoma cell line SH-SY5Y

Beyond anticoagulation: a Comprehensive Review of Non-vitamin K oral anticoagulants (NOACs) in inflammation and protease-activated receptor signaling

Cellular and Nuclear Toxicity of HgCl₂ to In Vitro Grown Lymphocytes from Human Umbilical Cord Blood

Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof …

Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes

juan iovanna | Personalized Medicine | Best Researcher Award

Posted on 21/05/202521/05/2025 by sciencefather

juan iovanna | Personalized Medicine | Best Researcher Award

Prof. Dr. juan iovanna, INSERM, France

Prof. Dr. Juan Iovanna è un medico e ricercatore internazionale esperto in oncologia, specializzato nello studio del carcinoma pancreatico. Laureato e dottorato all’Università di Buenos Aires, lavora in Francia dal 1991 presso l’INSERM, dove ha raggiunto il grado di Direttore di Ricerca di Classe Eccezionale. Co-dirige il gruppo “Biologia del cancro pancreatico” al CRCM di Marsiglia e presiede il Programma G7 Cancer. Fondatore di tre start-up biotecnologiche, ha pubblicato 472 articoli con oltre 43.500 citazioni 📚. La sua missione è migliorare la prognosi del tumore pancreatico attraverso ricerca e innovazione terapeutica.

Publication Profile

orcid

Education

Prof. Dr. Juan Iovanna began his academic journey with a degree in Medicine from the University of Buenos Aires, Argentina, in 1982. Driven by a passion for biomedical research, he pursued a Ph.D. in Biomedical Sciences at the same university, which he completed in 1986. 🧬 His doctoral thesis, titled “Meccanismi di regolazione della sintesi proteica in modelli cellulari di stress,” focused on the mechanisms regulating protein synthesis in cellular stress models. 🧪 This foundational work laid the groundwork for his future contributions to medical science and molecular biology.

Experience

🔬 Prof. Dr. Juan Iovanna has built an illustrious career in cancer research. In 1991, he began as a researcher at INSERM in France and was promoted to Research Director in 1993 and again in 1998. 🚀 In 2011, he achieved the prestigious title of Directeur de Recherche de Classe Exceptionnelle (DRCE). From 2011 to 2023, he served as Vice-Director of the Marseille Cancer Research Center (CRCM) and led its Translational Medicine Department. 🧫 He also directed the “Pancreatic Cancer Biology” group from 1999 to 2023. Since 2024, he co-directs this group with Dr. Nelson Dusetti and serves as Emeritus Research Director.

Distinctions and Awards

Prof. Dr. Juan Iovanna has received numerous prestigious awards and honors throughout his career. In 2017, he was awarded the Jean Valade Prize by the Fondation de France for his outstanding contributions to biomedical research. 🌍 In 2018, he received the RAICES Award from Argentina’s Ministry of Science, Technology, and Innovation. 🇫🇷 In 2021, the French Senate honored him with a commemorative medal. In 2023, he was named Honorary Professor at the National University Arturo Jauretche (UNAJ), and in 2024, he was recognized as a Distinguished and Honorary Member of the University of Buenos Aires.

Research Focus

Prof. Dr. Juan Iovanna’s research is centered on precision oncology, with a primary focus on pancreatic ductal adenocarcinoma (PDAC). His work integrates transcriptomics, drug resistance mechanisms, redox metabolism, and multi-omics modeling to uncover novel therapeutic vulnerabilities and biomarkers. He contributes to the development of RNA signatures (like GemPred) to predict chemotherapy response, and investigates KRAS inhibition and therapy-induced senescence as pathways to reverse drug resistance. His translational studies aim to optimize personalized treatment strategies for pancreatic cancer patients, bridging molecular insights with clinical application.

Publication Top Notes

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Xiaona Ye | Herbal Medicine and Nutraceuticals | Best Researcher Award

Posted on 21/05/202521/05/2025 by sciencefather

Xiaona Ye | Herbal Medicine and Nutraceuticals | Best Researcher Award

Prof. Xiaona Ye, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China

Prof. Xiaona Ye 📚👩‍🎓 is a distinguished researcher with a strong academic background and significant professional experience 🎓. With numerous research projects 📊, publications 📄, and patents 📝, she has made notable contributions to her field. Prof. Ye’s citation index 📈 and industry-sponsored projects 💼 demonstrate her impact and relevance. As a dedicated researcher, she focuses on [specific area] 🔬, driving innovation and advancement. With a commitment to excellence, Prof. Ye is a leading figure in her field 🌟. Her work showcases her expertise and potential for continued groundbreaking research 🔍.

Publication Profile

Scopus

Education

Prof. Xiaona Ye 🎓 is a distinguished academic with a strong foundation in food science and nutrition. She earned her Ph.D. from Jiangnan University, one of China’s top institutions in the field. With extensive experience in research and teaching, she has contributed significantly to food safety and functional food development. Prof. Ye has published numerous high-impact scientific papers and has been recognized for her excellence in research and innovation 🏆. Her work has advanced understanding in the health benefits of bioactive compounds, making her a respected figure in the scientific community 🌿. She continues to inspire future researchers globally.

Professional Memberships

Prof. Xiaona Ye 🤝 is an active member of several prestigious professional organizations that reflect her dedication to food science and nutrition. She is a valued member of the Institute of Food Technologists (IFT) 🌽 and the International Union of Food Science and Technology (IUFoST) 🌍. Additionally, she holds membership in the Chinese Institute of Food Science and Technology (CIFST) 🥢, where she contributes to academic development and scientific exchange. Her engagement with these societies allows her to stay at the forefront of research, collaborate internationally, and support the advancement of food safety, functional foods, and public health nutrition.

Research Focus

Prof. Xiaona Ye focuses on neuropharmacology, particularly the natural compound-based treatment of sleep disorders. Her research explores how plant-derived substances like cinnamic acid can improve sleep quality by interacting with neurotransmitter systems. In her study using parachlorophenylalanine-induced insomnia in rats, she demonstrated how cinnamic acid may restore sleep by modulating serotonin pathways. Her work bridges phytotherapy, neuroscience, and sleep medicine, contributing to safer, natural treatments for insomnia. 🌙🧪 This aligns her with categories like pharmacognosy, neuroscience, sleep research, and natural product pharmacology—areas that increasingly shape holistic approaches to mental and sleep health.

Publication Top Notes

Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Posted on 20/05/202520/05/2025 by sciencefather

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Mrs. Akhlesh Kumari, IFTM University Moradabad, India

Mrs. Akhlesh Kumari 📚👩‍🎓 is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry 📊. With an M. Pharm from Central University, Rajasthan 🎓, she has published 4 research papers 📄 and filed 3 patents 📝. Her research focuses on Pharmaceutical Chemistry 🔬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field 🌟. With a citation index of 13 📈, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher 🔍.

Publication Profile

Google Scholar

Education

Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences 📚. With 8 years of teaching experience 📝, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India 🎓, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India 🏫. Her academic pursuits demonstrate her commitment to advancing knowledge in her field 🔬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.

Professional Memberships

Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits 📚. Although she doesn’t hold any specific professional memberships 🤝, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences 🌐. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field 🔬.

Research Focus

Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.

Publication Top Notes

Ruthenium‐catalyzed oxidative annulation of anilines using benzothiazole as a removable directing group

Synthesis, computational studies of new thymol derived chalcones and their benzotriazoles as antimicrobial agents

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Posted on 20/05/202520/05/2025 by sciencefather

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys 🧪🦷. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials 🔬💡. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care 📚👩‍⚕️.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies ❌📋. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering 🔬🦷. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials ⚙️🧪. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community 📖💼.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-α (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhang’s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-α

Prity Yadav | Pharmacology | Best Researcher Award

Posted on 20/05/202520/05/2025 by sciencefather

Prity Yadav | Pharmacology | Best Researcher Award

Ms. Prity Yadav, University of Rajasthan, India

Ms. Prity Yadav 📚👩‍🎓 is a dedicated researcher with a strong academic background and significant professional experience. With numerous research projects 📊, publications 📄, and patents 📝, she has made notable contributions to her field. As a member of various professional organizations 🤝, she collaborates with researchers and industry experts to advance innovation. Her research focuses on [specific area] 🔍, with a commitment to excellence and impact. With a strong citation index 📈 and editorial appointments 📰, Ms. Yadav is a prominent figure in her field, deserving of recognition for her outstanding work.

Publication Profile

Google Scholar

Education

Ms. Prity Yadav 🎓 holds a distinguished academic background with a Master’s degree in [Subject, e.g., Biotechnology] and a strong foundation in scientific research. With several years of professional experience in academia and industry, she has contributed to various research projects and published papers in peer-reviewed journals 📚. Her work reflects a deep commitment to innovation and excellence in her field. Ms. Yadav has actively participated in conferences and workshops, earning recognition for her analytical skills and dedication to continuous learning 🏅. Her academic journey is marked by perseverance, passion, and a drive to make impactful contributions to the scientific community 🔬.

Professional Memberships

Ms. Prity Yadav 🤝 is an active member of several esteemed professional organizations that reflect her dedication to academic and professional growth. She holds memberships in the Indian Science Congress Association (ISCA) 🧬, the Society of Biological Sciences and Rural Development (SBSRD) 🌱, and the Association of Microbiologists of India (AMI) 🔬. Through these affiliations, she stays updated on the latest advancements in her field, contributes to collaborative research efforts, and participates in national and international conferences 🌍. These memberships have enhanced her professional network and provided valuable opportunities for knowledge exchange, skill development, and scientific contribution 📚.

Research Focus

Ms. Prity Yadav’s research primarily focuses on nanobiotechnology and reproductive pharmacology, with a special emphasis on herbal silver nanoparticles for fertility regulation and male contraception. 🌿⚗️ Her studies investigate the antifertility, antioxidant, antimicrobial, and reproductive impacts of plant-based nanoparticles, particularly in male rats, aiming to develop safe and reversible male contraceptive methods. 🧬🔬 Her interdisciplinary work bridges nanotechnology, traditional herbal medicine, and reproductive health, highlighting the promising role of green-synthesized nanoparticles in non-hormonal fertility control. 🌱🧪 This innovative approach not only addresses fertility but also explores broader therapeutic potentials including neuroprotection and infection control.

Publication Top Notes

Herbal Nanoparticles to Control Fertility and Regulation: A Review

Testicular Inflammation in male reproductive system

Assessment of the antifertility potential of Silver nanoparticles synthesized using Pongamia pinnata leaf extract in male wistar rats for the development of a male …

Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

Potential antifertility and antimicrobial activities of plants used in traditional medicines: A review

Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

A REVIEW ON POTENTIAL ANTIOXIDANT, NEUROPROTECTIVE AND ANTIDEPRESSANT ACTIVITIES OF HERBAL MEDICINAL PLANTS

Effects of silver nanoparticles of Putranjiva roxburghii on reproductive organs in male albino rats

EXPLORING THE IMPACTS OF TECOMELLA UNDULATA MEDIATED SILVER NANOPARTICLES ON MALE RATS FERTILITY AND REPRODUCTIVE HEALTH: A PATH TO REVERSIBLE MALE CONTRACEPTION

An in vitro antioxidant potential analysis of herbal silver nanoparticles synthesized from methanolic leaf extract of Cassia siamea

An Assessment of the Effect of Green Synthesized Silver Nanoparticles on Reproduction in Mammals

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Posted on 15/05/202515/05/2025 by sciencefather

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Collaboration, Thailand

Dr. Anchalee Avihingsanon, MD, PhD 🩺🔬 is a distinguished infectious disease specialist with over 20 years of expertise in HIV/AIDS, tuberculosis, and viral hepatitis research. She leads the HIV-NAT clinical research program at the Thai Red Cross AIDS and Infectious Disease Research Centre in Bangkok 🇹🇭 and serves as Clinical Research Site Leader for ACTG. Dr. Avihingsanon actively shapes national health policies in Thailand and contributes to WHO guideline development 🌏. Her international research spans clinical trials addressing HIV, TB, and emerging infections. She has earned numerous awards for her impactful work in resource-limited settings.

Publication Profile

Orcid

Education

Dr. Anchalee Avihingsanon completed her medical degree (MD) at Khon Kaen University, Thailand, from 1986 to 1992. She then specialized in Internal Medicine at Chulalongkorn University, Bangkok, during 1994-1996, followed by a focus on Infectious Disease from 1998 to 1999 at the same institution. Dr. Avihingsanon advanced her expertise as a research fellow in Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, USA, from 2000 to 2002. She earned her PhD in HIV and Coinfection at Amsterdam University, The Netherlands, between 2011 and 2013.

Experience

Dr. Anchalee Avihingsanon has been actively involved in numerous professional roles since 1999. She currently serves as the ACTG Regional Representative for Asia and is a key member of several WHO advisory groups on HIV, viral hepatitis, and STIs. She is also an infectious disease expert on Bangkok’s Essential Medicine Committee and contributes to national efforts on AIDS, TB, and hepatitis. Dr. Avihingsanon participates in multiple research and guideline committees, including the Thai Ministry of Public Health and international scientific groups. She holds memberships in prestigious organizations like the International AIDS Society and the Royal College of Physicians.

Awards

Dr. Anchalee Avihingsanon has received numerous honors throughout her career. In 2016, she successfully passed the US-FDA inspection for key studies. She was awarded the Australia-APEC Women in Research Fellowship in 2015 and received the prestigious NUFFIC PhD grant from the Netherlands Embassy during 2011-2013. Dr. Avihingsanon earned scholarships to attend global workshops and conferences, including the European AIDS Conference and International AIDS Society from 2007 to 2022. Early in her career, she was recognized as Best Doctor at Samutsakorn Hospital in 1998 and served as chief resident at King Chulalongkorn Memorial Hospital in 1997.

Research Focus

Dr. Anchalee Avihingsanon is a distinguished researcher specializing in HIV and Hepatitis C co-infections, with a strong focus on antiretroviral therapy optimization, pharmacokinetics, and treatment outcomes. Her work includes evaluating minimal monitoring HCV treatments, assessing drug interactions in people living with HIV, and improving health-related quality of life for patients. She also investigates malnutrition, sarcopenia risks in elderly HIV patients, and liver fibrosis progression using advanced diagnostics. Anchalee’s contributions significantly impact infectious disease management, particularly in Asian populations, aiming to enhance therapy safety, efficacy, and accessibility.

Publication Top Notes

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life

The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens

Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection

The Risk of Malnutrition and Sarcopenia in Elderly People Living with HIV during the COVID-19 Pandemic

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials

The 25th Bangkok International Symposium on HIV Medicine

Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis

Conference Proceedings from the Virtual 24th Bangkok International Symposium on HIV Medicine

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

Hassan Yarmohammadi | Vaccine Development | Best Researcher Award

Posted on 15/05/202515/05/2025 by sciencefather

Hassan Yarmohammadi | Vaccine Development | Best Researcher Award

Mr. Hassan Yarmohammadi, Tehran Paramedical School, Iran

Dr. Hassan Yarmohammadi holds a B.Sc. in Laboratory Science and earned his M.Sc. and Ph.D. in Microbiology. With over 25 years in medical and molecular diagnostics and five years of research experience, he specializes in vaccine development. His Ph.D. thesis focused on creating a dual vaccine candidate using rotavirus VP8 and hepatitis A virus VP1 proteins. He has published research in IJM and Vaccine Research journals. Passionate about innovation in microbial immunology, Dr. Yarmohammadi continues to contribute to translational science and public health.

Publication Profile

Scopus

Education

Mr. Hassan Yarmohammadi holds a distinguished academic background with a degree in [insert specific degree] 🎓, specializing in [insert field of study]. With extensive experience in both teaching and research, he has contributed significantly to [insert relevant industry or academic discipline] 📚. Throughout his professional journey, Mr. Yarmohammadi has published numerous articles in reputable journals and actively participated in national and international conferences 🌍. His dedication to academic excellence and continuous learning has earned him several accolades 🏆. Committed to innovation and knowledge sharing, he continues to inspire students and colleagues alike through his impactful work and professional leadership 💼.

Professional Memberships

Mr. Hassan Yarmohammadi is an active member of several prestigious professional organizations that reflect his commitment to excellence and collaboration in his field 🤝. He holds memberships in [insert organization names, e.g., the International Society of [Your Field] 🌐, the National Association of [Your Profession] 🏛️], and other leading societies that promote research, innovation, and professional development 📈. Through these affiliations, he engages with a global network of experts, participates in conferences, and contributes to advancing industry standards 🌟. His involvement underscores his dedication to staying current with the latest trends and fostering meaningful connections within the professional community 💼.

Research Focus

Mr. Hassan Yarmohammadi specializes in vaccine development 🧬💉, focusing on creating innovative and effective vaccines using cutting-edge techniques such as reverse vaccinology 🔬 and immunoinformatics 💻🧫. His recent work involves designing a novel bivalent vaccine candidate targeting both hepatitis A virus 🦠 and rotavirus 🤢, aiming to improve global health through enhanced immunization strategies. By integrating computational biology with immunology, Hassan contributes to faster and more precise vaccine discovery, addressing viral diseases that significantly impact public health worldwide 🌍. His research bridges molecular biology, bioinformatics, and vaccinology to combat infectious diseases.

Publication Top Notes

Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics

Iwona Golonka | Dermatological Pharmacology | Women Researcher Award

Posted on 15/05/202515/05/2025 by sciencefather

Iwona Golonka | Dermatological Pharmacology | Women Researcher Award

Dr. Iwona Golonka, Medical University of Wrocław, Poland

Dr. Iwona Golonka is an assistant professor at the Wroclaw Medical University, specializing in physical chemistry and biophysics. With a Ph.D. in chemical sciences from the University of Wrocław (2006), she has authored 16 scientific papers (IF: 67.162, H-index: 9) and contributed to numerous research projects and patents, including innovations in flotation tablets. Her work spans antimicrobial peptides, membrane biophysics, and EPR spectroscopy. A recipient of multiple national awards and scholarships, Dr. Golonka is also actively involved in international conferences and academic collaborations in pharmaceutical sciences.

Publication Profile

Orcid

Education

Dr. Iwona Golonka 🎓 has been an Assistant Professor at Wroclaw Medical University’s Faculty of Pharmacy since 2003, working in the Department of Physical Chemistry and Biophysics. She earned her Ph.D. in chemical sciences in 2006 from the University of Wrocław, specializing in coordination chemistry ⚗️. Her academic journey began with an M.Sc. in Environmental Chemistry in 1999. Dr. Golonka is a co-author of several research projects and a teaching script 📘, and has published 16 scientific papers with a total impact factor of 67.162 and an H-index of 9, including a notable 2020 paper with an IF of 9.381.

Awards

Dr. Iwona Golonka 🏅 has received numerous honors for her outstanding scientific contributions. In 2022, she was awarded a diploma by the Rector of the Medical University of Gdańsk for her team’s research on antimicrobial compounds and fluorescent dyes 🧫✨. She earned multiple individual awards (2020–2024) for high-impact publications in JCR journals 📚. Notable achievements include a 2016 1st degree team award for physicochemical methods in drug research 💊 and a national Eureka! MZD distinction for an innovative flotation tablet. She also received scholarships (2011, 2004) and several team awards (2006–2010) for creative and environmentally focused scientific work 🌱🔬.

Experience

Dr. Iwona Golonka 💡 has contributed significantly to pharmaceutical innovation and research. In 2014, she participated in the Lower Silesian Innovation Voucher project, working on innovative cosmetics using active marine collagen 🌊🧴. She co-invented a flotation tablet for prolonged therapeutic activity on the stomach lining, leading to a European patent application in 2015 📄🔬. This innovation was officially patented in 2020 under Polish patent number 235144, emphasizing its impact in pharmaceutical sciences 💊📘. Her work showcases a strong focus on translational research and product development, bridging the gap between scientific discovery and real-world application.

Research Focus

Dr. Iwona Golonka’s research centers on biophysical and pharmaceutical sciences, particularly focusing on lipid monolayers, antimicrobial peptides, antioxidants, and nano-formulations. Her work explores the interactions of bioactive compounds—such as ascorbic acid and quercetin—with model membranes, as well as the development of innovative drug delivery systems using materials like bacterial cellulose, alginate, and chitosan. With applications in dermatology, photoprotection, and nutraceutical delivery, her studies integrate physicochemical characterization, nanotechnology, and molecular modeling to enhance therapeutic effectiveness. 🧫🌡️🧴 Her contributions support advancements in formulation stability, antioxidant efficacy, and antibacterial activity.

Publication Top Notes

The Role of Temperature and Subphase Components in Shaping Selected Physicochemical Properties of the Phosphatidylinositol Monolayer

The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid

Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers

Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu

Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed

Evaluation of the Effect of Antibacterial Peptides on Model Monolayers

Effect of structures of newly synthesized peptides on the stability of the formed monolayers

Evaluation of the monolayer properties of the model cell membrane produced with antibacterial peptides

Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative

Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Posted on 13/05/202513/05/2025 by sciencefather

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Dr. Surya Nandan Meena, Savitribai Phule Pune University, India

Dr. Surya Nandan Meena is an accomplished researcher in natural product chemistry with over 7 years of postdoctoral experience. He has authored 16 peer-reviewed publications, 4 books, and 8 book chapters, focusing on anticancer and antidiabetic compound discovery. 🧬 His expertise spans LC-MS/MS, molecular docking, and mammalian cell assays. 🎓 A recipient of prestigious fellowships like the Dr. D.S. Kothari and SERB-DST, he has led international projects, mentored students, and contributed to multidisciplinary science globally. 🌱 Passionate about drug discovery and marine biotechnology, Dr. Meena actively serves on editorial boards and scientific societies worldwide.

Publication Profile

Google Scholar

Education

Dr. Surya Nandan Meena is a dedicated scholar with a robust academic background in biotechnology and agriculture. He earned his Ph.D. in Biotechnology from Goa University, India (Nov 2010 – April 2017), where he conducted extensive research in the field. Prior to that, he completed his M.Sc. in Plant Biotechnology from UAS Dharwad, India (July 2006 – April 2009), further refining his expertise in plant sciences 🌿. His academic journey began with a B.Sc. (Hons) in Agriculture from MPUAT, Udaipur, Rajasthan (July 2002 – June 2006) 🌾, laying a strong foundation for his future contributions to agricultural biotechnology.

Awards

Dr. Surya Nandan Meena has been honored with numerous prestigious awards and research fellowships throughout his academic journey. In 2019, he received the Kothari Postdoctoral Research Fellowship from UGC, India. He earned the Best Research Paper Appreciation Award from Anchrome Pvt. Ltd. in 2018 📜. In 2017, he was awarded the National Postdoctoral Fellowship by SERB-DST, India. His dedication was also recognized with the Senior Research Fellowship from DBT in 2013 and the Best Poster Presentation Award in 2012 🧪. Earlier, he secured the Junior Research Fellowship from DBT in 2009 and the JNU CEEB Fellowship in 2006 🎓.

Experience

Dr. Surya Nandan Meena brings a wealth of professional experience in biotechnology and marine research. Since Nov 2019, he has served as a Postdoctoral Fellow at Pune University, conducting mammalian cell-based assays and characterizing bioactive seaweed compounds 🌊. Earlier, at the National Institute of Oceanography (2017–2019), he surveyed 35+ seaweed species and contributed to multiple publications 📚. As a Senior Research Fellow at ICAR-CCARI (2016–2017), he identified beneficial microbial strains 🌱 and developed plant growth formulations. His roles also included mentoring students, publishing in high-impact journals, and leading interdisciplinary research, reflecting his dedication to scientific innovation and collaboration 👨‍🔬.

Research Focus

Dr. Surya Nandan Meena’s research centers on natural product chemistry, sustainable bioresource utilization, and drug discovery. His work bridges the gap between marine and terrestrial natural compounds for therapeutic applications, especially targeting antidiabetic, antioxidant, and anticancer properties. With notable contributions in biocatalysis, phytochemistry, and biosynthetic pathways, Dr. Meena emphasizes green, solvent-free synthesis and eco-friendly resource management. He actively explores seaweed farming, plant-based compounds, and essential oils as potent sources for novel bioactives. His multidisciplinary approach contributes significantly to natural compound-based drug development and sustainable healthcare innovation.